Allecra reports Phase II data for AAI101 combo to treat cUTI

Allecra Therapeutics GmbH (Lörrach, Germany) reported top-line data from the Phase II CACTUS trial in 45 hospitalized adults with complicated urinary tract

Read the full 227 word article

User Sign In